Cite
Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing.
MLA
Sheffield, Brandon S., et al. “Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing.” PLoS ONE, vol. 10, no. 3, Mar. 2015, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0119689.
APA
Sheffield, B. S., Tinker, A. V., Shen, Y., Hwang, H., Li-Chang, H. H., Pleasance, E., Ch, ng, C., Lum, A., Lorette, J., McConnell, Y. J., Sun, S., Jones, S. J. M., Gown, A. M., Huntsman, D. G., Schaeffer, D. F., Churg, A., Yip, S., Laskin, J., & Marra, M. A. (2015). Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing. PLoS ONE, 10(3), 1–12. https://doi.org/10.1371/journal.pone.0119689
Chicago
Sheffield, Brandon S., Anna V. Tinker, Yaoqing Shen, Harry Hwang, Hector H. Li-Chang, Erin Pleasance, ng, Carolyn Ch, et al. 2015. “Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing.” PLoS ONE 10 (3): 1–12. doi:10.1371/journal.pone.0119689.